Continuous glucose monitoring reveals bimodal glycemic patterns during and outside Capivasertib administration

ABSTRACT Capivasertib, an AKT inhibitor, interferes with insulin signaling and can induce hyperglycemia. In this case, we monitored blood glucose fluctuations using continuous glucose monitoring (CGM) during capivasertib administration. During the administration period, a post‐dose increase in blood...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Yuya Suzuki, Takeshi Yamaguchi, Takayasu Uchida, Kimio Matsumura, Nozomi Harai, Kaoru Nagasawa, Yuko Tanabe, Koichi Suyama, Takashi Kadowaki, Yasumichi Mori
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2026-04-01
Serija:	Journal of Diabetes Investigation
Teme:	Capivasertib Continuous glucose monitoring Hyperglycemia
Online dostop:	https://doi.org/10.1111/jdi.70261
Oznake:	Označite Brez oznak, prvi označite!